descriptionPublicationkeyboard_double_arrow_right Article 19 Sep 2013 English Publisher:American Society of HematologyJournal:Blood, volume 122, pages 2,001-2,001 (issn: 0006-4971, eissn: 1528-0020,

Authors: Michele R. Roullet; Armin Rashidi;

doi: 10.1182/blood-2013-05-500157

pmid: 24175353

Romiplostim-induced myelofibrosis

- Summary
- Subjects
- Metrics

Abstract

![Figure][1] A 55-year-old woman with chronic refractory idiopathic thrombocytopenic purpura (ITP) presented with gum bleeding for 1 day. Over the course of several years, she had failed, or became resistant to, multiple treatments including glucocorticoids, intravenous immunoglobulin,

Related Organizations

Eastern Virginia Medical School
United States

Keywords

Purpura, Thrombocytopenic, Idiopathic, Thrombopoietin, Bone Marrow, Primary Myelofibrosis, Recombinant Fusion Proteins, Humans, Female, Receptors, Fc, Middle Aged, Receptors, Thrombopoietin

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	10
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%